BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiou YH, Wang LY, Wang TH, Huang SP. Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome. Pediatr Nephrol 2012;27:1511-7. [PMID: 22610055 DOI: 10.1007/s00467-012-2182-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Schijvens AM, Ter Heine R, de Wildt SN, Schreuder MF. Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome. Pediatr Nephrol 2019;34:389-403. [PMID: 29549463 DOI: 10.1007/s00467-018-3929-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
2 Tziastoudi M, Pissas G, Raptis G, Cholevas C, Eleftheriadis T, Dounousi E, Stefanidis I, Theoharides TC. A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease. Int J Mol Sci 2021;22:4480. [PMID: 33923087 DOI: 10.3390/ijms22094480] [Reference Citation Analysis]
3 Youssef DM, Attia TA, El-Shal AS, Abduelometty FA. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids. Gene 2013;530:201-7. [PMID: 23994685 DOI: 10.1016/j.gene.2013.08.045] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
4 Lane BM, Cason R, Esezobor CI, Gbadegesin RA. Genetics of Childhood Steroid Sensitive Nephrotic Syndrome: An Update. Front Pediatr 2019;7:8. [PMID: 30761277 DOI: 10.3389/fped.2019.00008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
5 Reis FM, Coutinho LM, Vannuccini S, Batteux F, Chapron C, Petraglia F. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure. Hum Reprod Update 2020;26:565-85. [PMID: 32412587 DOI: 10.1093/humupd/dmaa009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
6 Safan MA, Elhelbawy NG, Midan DA, Khader HF. ABCB1 polymorphisms and steroid treatment in children with idiopathic nephrotic syndrome. Br J Biomed Sci 2017;74:36-41. [PMID: 27719329 DOI: 10.1080/09674845.2016.1220707] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hejazian SM, Zununi Vahed S, Moghaddas Sani H, Nariman-Saleh-Fam Z, Bastami M, Hosseiniyan Khatibi SM, Ardalan M, Samadi N. Steroid-resistant nephrotic syndrome: pharmacogenetics and epigenetic points and views. Expert Rev Clin Pharmacol 2020;13:147-56. [PMID: 31847609 DOI: 10.1080/17512433.2020.1702877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Parvin MN, Aziz MA, Rabbi SNI, Al-Mamun MMA, Hanif M, Islam MS, Islam MS. Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach. J Adv Res 2021;33:141-51. [PMID: 34603785 DOI: 10.1016/j.jare.2021.02.001] [Reference Citation Analysis]
9 Skauby RH, Bjerre A, Sæves I, Vethe NT, Bremer S, Svarstad A, Bergan S. Prednisolone and Prednisone Pharmacokinetics in Pediatric Renal Transplant Recipients—A Prospective Study. Therapeutic Drug Monitoring 2017;39:472-82. [DOI: 10.1097/ftd.0000000000000439] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Skauby RH, Gustavsen MT, Andersen AM, Bjerre A, Åsberg A, Midtvedt K, Vethe NT, Bergan S. Prednisolone and Prednisone Pharmacokinetics in Adult Renal Transplant Recipients. Ther Drug Monit 2021;43:247-55. [PMID: 33181621 DOI: 10.1097/FTD.0000000000000835] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 El-Beblawy NM, Elbarbary NS, Kamal TM, Mahmoud PM. A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia. Clin Appl Thromb Hemost 2016;22:429-40. [PMID: 25792670 DOI: 10.1177/1076029615576738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Song QQ, Xie WY, Tang YJ, Zhang J, Liu J. Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment. Pharmacogenomics 2017;18:293-316. [PMID: 28112586 DOI: 10.2217/pgs-2016-0151] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
13 Han SS, Xu YQ, Lu Y, Gu XC, Wang Y. A PRISMA-compliant meta-analysis of MDR1 polymorphisms and idiopathic nephrotic syndrome: Susceptibility and steroid responsiveness. Medicine (Baltimore) 2017;96:e7191. [PMID: 28614261 DOI: 10.1097/MD.0000000000007191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
14 Cuzzoni E, De Iudicibus S, Franca R, Stocco G, Lucafò M, Pelin M, Favretto D, Pasini A, Montini G, Decorti G. Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome. Pharmacogenomics 2015;16:1631-48. [PMID: 26419298 DOI: 10.2217/pgs.15.101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]